What Does the Study From the Journal of the American Medical Association Mean For Cannabis
The Journal of the American Medical Association recently released a study that explained prescription opioids are cannot manage America’s persistent pain problem. The research study went on to state that Tylenol is just as good as Vicodin at assisting the over 100 million Americans that contend with routine persistent pain.
The medical neighborhood needs to find a service to the chronic pain concern facing the nation and if opioids and acetaminophen can not do it, cannabis is the next rational choice. Medical marijuana has many supporters that offer testaments on the relief they obtain from their chronic pain with cannabis. In states that have a legal medical cannabis program, persistent pain is often on the list of certifying conditions.
A study released in the Journal of the American Medical Association compared opioids (Vicodin, oxycodone, and fentanyl) to non-opioids (Tylenol, ibuprofen, and nerve blockers) to see if they were much better at dealing with persistent back, hip, or knee discomfort. The response was clear: They were not. “Treatment with opioids was not superior to treatment with non-opioids for improving pain-related function over 12 months,” the study reads. “Results do not support initiation of opioid treatment for moderate to severe chronic back pain or hip or knee osteoarthritis pain.”
The news is a major blow for pharmaceutical companies like Purdue Pharma, who have made billions through prescription painkillers, but it’s even worse news for those suffering the effects of persistent discomfort. The question it leaves behind: If opioids aren’t the response to chronic pain, exactly what is?
For a growing number of medical professionals, the answer can be found in the type of another less unsafe drug: marijuana. This past November, 3 physicians in Illinois started a campaign called Physicians Against Injurious Narcotics, or PAIN, which aims to expand the state’s medical marijuana program to enable anybody that gets approved for opioids to likewise qualify for cannabis.